Researchers from the University of Chemistry and Technology Prague and the Institute for Clinical and Experimental Medicine have found that cannabidiolic acid (CBDA) has far stronger bioavailability than cannabidiol (CBD), making it a potentially underutilized therapeutic compound. The study, which is being published in the November 2025 issue of the International Journal of Pharmaceutics, tested … Continue reading Study: CBDA Shows Far Greater Bioavailability Than CBD in Animal and Cell Models